PBPH Among Health Care ETFs
End-of-day Nov 19, 2026 · 32 Health care ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.7% | −4.8% | +1.0% | +1.5% | +18.9% | — | — | — | — | +19.7% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$170 of every $1,000 in PBPH is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLY.TOELI Lilly | Healthcare | 16.96% | $1,696.30 | 168K | $232.2M |
| 2 | JNJ.TOJohnson & Johnson | Healthcare | 9.57% | $957.27 | 480K | $131.0M |
| 3 | ABBVAbbvie | Healthcare | 7.36% | $735.73 | 352K | $100.7M |
| 4 | MRKMerck | Healthcare | 4.96% | $495.70 | 492K | $67.8M |
| 5 | —Roche AG | — | 4.93% | $492.60 | 141K | $67.4M |
| 6 | AZN.LAstrazeneca | Healthcare | 4.71% | $470.71 | 359K | $64.4M |
| 7 | AMGNAmgen | Healthcare | 4.28% | $428.05 | 132K | $58.6M |
| 8 | GILD.TOGilead Sciences | Healthcare | 4.17% | $416.77 | 338K | $57.0M |
| 9 | NOVN.SWNovartis Ag-reg | Healthcare | 4.13% | $413.34 | 363K | $56.6M |
| 10 | PFE.BAPfizer | Healthcare | 3.18% | $318.47 | 1.6M | $43.6M |
| 11 | VRTXVertex Pharmaceuticals | Healthcare | 2.69% | $268.96 | 69K | $36.8M |
| 12 | —Novo Nordisk A/s-b | — | 2.53% | $252.80 | 869K | $34.6M |
| 13 | BMYBristol-myers Squibb | Healthcare | 2.42% | $242.20 | 557K | $33.2M |
| 14 | SAN.PASanofi | Healthcare | 2.04% | $203.69 | 295K | $27.9M |
| 15 | REGNRegeneron Pharmaceuticals | Healthcare | 1.87% | $186.63 | 27K | $25.5M |
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 24, 2025 | Dec 26, 2025 | $0.0230 |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY.TO | ELI Lilly & | 16.96% |
| 2 | JNJ.TO | Johnson & Johnson | 9.57% |
| 3 | ABBV | Abbvie | 7.36% |
| 4 | MRK | Merck & | 4.96% |
| 5 | AZN.L | Astrazeneca | 4.71% |
| 6 | AMGN | Amgen | 4.28% |
| 7 | GILD.TO | Gilead Sciences | 4.17% |
| 8 | NOVN.SW | Novartis Ag-reg | 4.13% |
| 9 | PFE.BA | Pfizer | 3.18% |
| 10 | VRTX | Vertex Pharmaceuticals | 2.69% |